Zytiga (Abiraterone Acetate)

Zytiga (Abiraterone Acetate) is an innovative medication primarily used in the treatment of metastatic castration-resistant prostate cancer. This targeted therapy works by inhibiting the production of androgens, hormones that can fuel the growth of prostate cancer cells. By blocking these hormones, Zytiga effectively reduces tumor growth and progression.

Here are some key highlights of Zytiga:

• Mechanism of Action: Zytiga acts by inhibiting the enzyme CYP17, which is crucial in the biosynthesis of androgens, thus lowering testosterone levels in the body.


• Combination Therapy: Often prescribed in conjunction with prednisone, Zytiga enhances its effectiveness while managing potential side effects related to hormone suppression.


• Administration: Taken orally, Zytiga is typically prescribed as four tablets once daily, and it is vital to take it on an empty stomach for optimal absorption.


• Clinical Efficacy: Clinical trials have demonstrated significant improvements in survival rates and quality of life for patients using Zytiga compared to those receiving placebo treatments.


• Side Effects: Common side effects may include fatigue, joint pain, hypertension, and liver enzyme elevations. Monitoring by healthcare professionals is essential during treatment.


• Indications: Besides metastatic castration-resistant prostate cancer, Zytiga is also utilized in earlier stages of prostate cancer in combination with hormonal therapy.


• Patient Support: Support programs are available to assist patients with access, education, and financial resources related to the medication.

Overall, Zytiga represents a significant advancement in prostate cancer treatment, providing hope and improved outcomes for many patients facing this challenging disease.

• Abiraterone Acetate


• Microcrystalline Cellulose


• Pregelatinized Starch


• Corn Starch


• Magnesium Stearate


• Hydroxypropyl Methylcellulose


• Titanium Dioxide


• Iron Oxide Yellow

Zytiga (Abiraterone Acetate) is a medication used primarily in the treatment of prostate cancer. To ensure effective use of this medication, follow these detailed instructions:

1. Consult your healthcare provider to confirm that Zytiga is appropriate for your condition. They will provide you with a prescription and discuss potential benefits and risks.




2. Take Zytiga exactly as prescribed by your doctor. The typical dosage is four 250 mg tablets taken once a day. Do not take more or less than directed.




3. It is recommended to take Zytiga on an empty stomach. Ensure that you have not eaten anything for at least 2 hours before taking the medication and wait at least 1 hour after taking it before consuming food.




4. Swallow the tablets whole with water. Do not crush or chew the tablets, as this can affect how the medication is absorbed into your body.




5. Take the medication at the same time each day to help maintain an even level of the drug in your system. Consider using a pill organizer or setting a daily reminder.




6. It is important to adhere to any additional treatments or medications prescribed by your doctor, as Zytiga is often used in conjunction with other therapies.




7. Regular monitoring through blood tests will be necessary to check your hormone levels and liver function. Attend all scheduled appointments with your healthcare provider.




8. If you miss a dose of Zytiga, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.




9. Store Zytiga at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets.




10. If you experience any side effects, such as fatigue, joint pain, or high blood pressure, contact your healthcare provider promptly for advice on how to manage these symptoms.

Following these instructions will help ensure that you use Zytiga safely and effectively. Always communicate openly with your healthcare team regarding any concerns or questions you may have during your treatment.